Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+3.44%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$11.6B
AUM Growth
-$483M
(-4%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-6.43%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
617
New
162
Increased
103
Reduced
150
Closed
187
Top Buys
| 1 |
Delta Air Lines
DAL
|
+$154M |
| 2 |
AbbVie
ABBV
|
+$128M |
| 3 |
KeyCorp
KEY
|
+$119M |
| 4 |
Walmart
WMT
|
+$110M |
| 5 |
F5
FFIV
|
+$108M |
Top Sells
| 1 |
Oracle
ORCL
|
+$161M |
| 2 |
S&P Global
SPGI
|
+$149M |
| 3 |
Labcorp
LH
|
+$142M |
| 4 |
Eli Lilly
LLY
|
+$133M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$130M |
Sector Composition
| 1 | Technology | 19.25% |
| 2 | Healthcare | 13.54% |
| 3 | Industrials | 12.35% |
| 4 | Consumer Discretionary | 10.54% |
| 5 | Financials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KREF
276
KKR Real Estate Finance Trust
KREF
$642M
| $4.3M | 0.04% |
+200,000
| New | +$4.3M |
|
277
MSCI
MSCI
$44B
| $4.22M | 0.04% |
41,017
+1,017
| +3% | +$105K |
|
278
Aurinia Pharmaceuticals
AUPH
$1.63B
| $4.1M | 0.03% |
669,346
-120,846
| -15% | -$741K |
|
279
Sportsman's Warehouse
SPWH
$115M
| $4.05M | 0.03% |
750,000
-191,450
| -20% | -$1.03M |
|
|
LOXO
280
DELISTED
Loxo Oncology, Inc
LOXO
| $4.01M | 0.03% |
+50,000
| New | +$4.01M |
|
281
Henry Schein
HSIC
$8.2B
| $4.01M | 0.03% |
+55,840
| New | +$4.01M |
|
|
CBIO
282
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $3.91M | 0.03% |
+3,500
| New | +$3.91M |
|
283
Neurogene
NGNE
$275M
| $3.91M | 0.03% |
13,876
+6,568
| +90% | +$1.85M |
|
284
Zevra Therapeutics
ZVRA
$461M
| $3.9M | 0.03% |
60,914
-1,347
| -2% | -$86.2K |
|
|
PRTK
285
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.85M | 0.03% |
+159,814
| New | +$3.85M |
|
286
Illinois Tool Works
ITW
$76.4B
| $3.84M | 0.03% |
+26,776
| New | +$3.84M |
|
287
Meta Platforms (Facebook)
META
$1.92T
| $3.77M | 0.03% |
24,951
-193,088
| -89% | -$29.2M |
|
|
BHVN
288
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.74M | 0.03% |
+149,651
| New | +$3.74M |
|
|
GMS
289
DELISTED
GMS Inc
GMS
| $3.72M | 0.03% |
+132,387
| New | +$3.72M |
|
|
MSCC
290
DELISTED
Microsemi Corp
MSCC
| $3.68M | 0.03% |
+78,593
| New | +$3.68M |
|
291
GDS Holdings
GDS
$6.56B
| $3.67M | 0.03% |
395,698
-235,080
| -37% | -$2.18M |
|
|
EXPR
292
DELISTED
Express, Inc.
EXPR
| $3.38M | 0.03% |
+25,000
| New | +$3.38M |
|
|
293
Oracle
ORCL
$678B
| $3.32M | 0.03% |
66,128
-3,204,010
| -98% | -$161M |
|
294
Stanley Black & Decker
SWK
$11.9B
| $3.17M | 0.03% |
+22,543
| New | +$3.17M |
|
|
AERI
295
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.15M | 0.03% |
60,000
+33,442
| +126% | +$1.76M |
|
|
BHI
296
DELISTED
Baker Hughes
BHI
| $3.08M | 0.03% |
+56,561
| New | +$3.08M |
|
|
SGBK
297
DELISTED
Stonegate Bank
SGBK
| $3.08M | 0.03% |
+66,596
| New | +$3.08M |
|
298
Aon
AON
$79B
| $3.05M | 0.03% |
+22,930
| New | +$3.05M |
|
299
Xylem
XYL
$33.5B
| $3.02M | 0.03% |
54,506
-36,813
| -40% | -$2.04M |
|
300
Ramaco Resources Class A
METC
$1.68B
| $2.87M | 0.02% |
490,956
+77,520
| +19% | +$454K |
|